twitter.com/i/events/1414668278014758915
The FDA adds new warning to Johnson & Johnson COVID-19 vaccine for rare side effect
The US Food and Drug Administration will soon add a warning label to Johnson & Johnson COVID-19 vaccines after about 100 people out of 12.8 million vaccinated patients developed Guillain-Barré syndrome, a largely recoverable neurological condition, according to multiple reports. The Biden administration is expected to announce the new warning as early as Tuesday, according to The New York Times. Officials are still encouraging people to seek vaccination, as the possible side effects of vaccines are much less deadly than the effects of COVID-19.
What you need to know:
– Guillain-Barré syndrome (GBS) is a neurological disorder that has been reported in about 100 out of 12.8 million Johnson & Johnson vaccine recipients, according to multiple reports.
– GBS is fully recoverable in most patients, according to multiple reports.
– The FDA says according to its evaluation of the J&J vaccine, it “continues to find the known and potential benefits clearly outweigh the known and potential risks,” according to The Washington Post.
h/t Uppity Me